Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Midcap & small cap buck trend
Mon, 17 Nov 01:30 pm

Indian share markets continued to trade below the dotted line in the post-noon trading session. Majority of the sectoral indices are trading in the red with metal and engineering stocks being the major losers. However, auto and power stocks are among the major gainers.

BSE-Sensex is down 54 points and NSE-Nifty is trading 22 points down. BSE Mid Cap is trading 0.5% up and BSE Small Cap index is trading up by 0.8%. The rupee is trading at 61.66 to the US dollar.

Domestic pharma stocks are trading mixed with Indoco Remedies and Dishman Pharma being the major gainers whereas Elder Pharma and Ranbaxy Lab are the biggest losers. As per a leading financial daily, the government is set to make it compulsory for all life saving drugs to carry a bold red strip on their packs from January 2015. The strip will highlight that the drugs are under Drug Price Control order and also specify the ceiling price per unit as fixed by the government. This move is likely to help consumers make informed choices while purchasing medicines. Consumers can directly call National Pharmaceutical Pricing Authority (NPPA) to file a complaint for overcharging. The government has also proposed to bring in 100 more drugs under Drug Price Control Order.

Majority of the energy stocks are trading in the green led by Castrol India and MRPL whereas Gujarat State Petronet and BPCL are among the major losers. As per a leading financial daily, ONGC would be investing Rs 106 bn in increasing production from its western offshore fields. The company board has approved the third phase of redevelopment of its Prime Mumbai High South oil and gas field at a cost of Rs 60.7 bn and the integrated development of Mukta, Bassein and Panna formations at an investment of Rs 46.2 bn. The Mumbai High South redevelopment (phase III) will expand the lifespan of the giant gasfield that has been in production for over three decades and is expected to be completed by March 2019. This will result in incremental gain of 7.547 million tonne crude oil and 3.864 bn cubic meter gas by 2030. The development of Mukta, Bassein and Panna formations will start yielding results in 2014-15 with 10 m standard cubic meters per day of gas and 950 barrels of oil per day by 2017-18. The project is scheduled for completion by April 2017. ONGC stock is currently trading up by 0.4%

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Midcap & small cap buck trend". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.